CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: June 6, 2013
Result type: Reports
Project Number: SR0337-000
Product Line: Reimbursement Review

Generic Name: Ocriplasmin

Brand Name: Jetrea

Manufacturer: Alcon Canada Inc.

Therapeutic Area: Vitreomacular adhesion

Indications: Vitreomacular adhesion

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: December 20, 2013

Recommendation Type: List with criteria/condition